iconEarnings Announcement After Market Close

GeoVax Labs Inc GOVX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/13/24 EDT
1.65quote price arrow up+0.09 (+5.77%)
Volume
27,638
52 week range
1.38 - 11.54
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.65
  • 52 Week High11.54
  • 52 Week High Date05/24/23
  • 52 Week Low1.38
  • 52 Week Low Date04/30/24

Key Stats

  • Market Cap3.809M
  • Shares Out2.31M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.74
  • YTD % Change-69.53

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.65
  • 52 Week High11.54
  • 52 Week High Date05/24/23
  • 52 Week Low1.38
  • 52 Week Low Date04/30/24
  • Market Cap3.809M
  • Shares Out2.31M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.74
  • YTD % Change-69.53

RATIOS/PROFITABILITY

  • EPS (TTM)-14.25
  • P/E (TTM)-0.12
  • Fwd P/E (NTM)-0.11
  • EBITDA (TTM)-26.669M
  • ROE (TTM)-160.47%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-17,197.51%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/14/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GeoVax Labs Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola...
David Dodd
Chairman of the Board, President, Chief Executive Officer
Mark Reynolds CPA
Chief Financial Officer, Corporate Secretary
Address
1900 Lake Park Drive, Suite 380
Smyrna, GA
30080
United States

Top Peers

SYMBOLLASTCHG%CHG
ENVB
Enveric Biosciences Inc
0.8406-0.0494-5.5506%
VIRI
Virios Therapeutics Inc
0.3541-0.0008-0.2254%
HEPA
Hepion Pharmaceuticals Inc
1.21-0.05-3.97%
TOVX
Theriva Biologics Inc
0.3741+0.0101+2.7747%
ADIL
Adial Pharmaceuticals Inc
1.45-0.05-3.67%